Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jun 28;22(24):5495-504.
doi: 10.3748/wjg.v22.i24.5495.

Current status of intragastric balloon for obesity treatment

Seung Han Kim  1 , Hoon Jai Chun  1 , Hyuk Soon Choi  1 , Eun Sun Kim  1 , Bora Keum  1 , Yoon Tae Jeen  1
Affiliations
Review

Current status of intragastric balloon for obesity treatment

Seung Han Kim et al. World J Gastroenterol. .

Abstract

Endoscopic bariatric therapy may be a useful alternative to pharmacological treatment for obesity, and it provides greater efficacy with lower risks than do conventional surgical procedures. Among the various endoscopic treatments for obesity, the intragastric balloon is associated with significant efficacy in body weight reduction and relief of comorbid disease symptoms. Anatomically, this treatment is based on gastric space-occupying effects that increase the feeling of satiety and may also affect gut neuroendocrine signaling. The simplicity of the intragastric balloon procedure may account for its widespread role in obesity treatment and its applicability to various degrees of obesity. However, advances in device properties and procedural techniques are still needed in order to improve its safety and cost-effectiveness. Furthermore, verification of the physiological outcomes of intragastric balloon treatment and the clinical predictive factors for treatment responses should be considered. In this article, we discuss the types, efficacy, safety, and future directions of intragastric balloon treatment.

Keywords: Bariatric; Endoscopy; Intragastric balloon; Metabolic; Obesity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Intragastric balloon placement.
Figure 2
Figure 2
Gastric ulcer induced by intragastric balloon placement.
See this image and copyright information in PMC

References

    1. Pi-Sunyer X. The medical risks of obesity. Postgrad Med. 2009;121:21–33. - PMC - PubMed
    1. Gregg EW, Chen H, Wagenknecht LE, Clark JM, Delahanty LM, Bantle J, Pownall HJ, Johnson KC, Safford MM, Kitabchi AE, et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA. 2012;308:2489–2496. - PMC - PubMed
    1. Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677–1686. - PMC - PubMed
    1. Look AHEAD Research Group. Eight-year weight losses with an intensive lifestyle intervention: the look AHEAD study. Obesity (Silver Spring) 2014;22:5–13. - PMC - PubMed
    1. Yanovski SZ, Yanovski JA. Long-term drug treatment for obesity: a systematic and clinical review. JAMA. 2014;311:74–86. - PMC - PubMed